Loading...
NPI 1104560945 · Tulsa, OK · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Labcorp Oklahoma, Inc. is a clinical medical laboratory provider located in Tulsa, Oklahoma. This profile covers 405 Medicare and 233 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Labcorp Oklahoma, Inc. |
| Address | 4144 S Mingo Rd |
| City | Tulsa |
| State | OK |
| ZIP | 74146 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 27, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $7.8M |
| Medicare | $6.8M |
Payer mix and scale: LABCORP OKLAHOMA, INC. reports $6.8M in lifetime Medicare revenue and $7.8M in lifetime Medicaid revenue, indicating Medicaid is the slightly larger payer relationship by revenue. Both payers contribute materially to the business rather than the entity being a single‑payer shop, so contract management and network positioning should account for both Medicare and state Medicaid terms.
Medicare revenue concentration: the provider’s top three Medicare codes (80053, 85025, 80061) together account for 36.2% of its total Medicare revenue, with 80053 generating $708.5K (14.6%), 85025 $543.2K (11.2%), and 80061 $508.3K (10.5%). This concentration around routine chemistry and hematology panels suggests much of Medicare income is driven by high-volume, lower-reimbursement routine testing.
Clinical service mix and operations: the Medicare code mix (80053 CMP, 85025 CBC, 80061 lipid panel, 84443 TSH, 82306 vitamin D, 83036 A1C, etc.) indicates a broad clinical laboratory performing high volumes of routine chemistry, hematology, endocrine, and metabolic monitoring assays. Claim counts are large (e.g., 80053: 70.9K claims; 85025: 67.9K claims; 36415 phlebotomy: 58.2K claims), consistent with a centralized phlebotomy/sample-processing operation servicing outpatient and ambulatory sources.
Medicare competitive standing: for several routine codes LABCORP OKLAHOMA ranks at or near the top nationally, with 80053 at #55 of 26416 providers (100th percentile; extreme outlier), 85025 at #48 of 32833 (100th percentile; extreme outlier), and 80061 at #57 of 21671 (100th percentile; notably above typical national volume). Multiple other codes (e.g., 36415, 83036, 84443) also sit at very high national percentiles, indicating a dominant national footprint for common diagnostic services on the Medicare side rather than a modest local lab.
Medicaid competitive standing in-state: the provider shows leading in-state positions on several Medicaid codes that point to market importance in Oklahoma for STD and infectious disease screening and COVID testing — 80050 ranks #4 of 39 in-state (92th percentile), 87591 and 87491 both rank #5 of 45 (91th percentile), and U0004 ranks #3 of 27 in-state (92th percentile). The provider also holds top in-state position for 86481 (rank #1 of 3, 100th percentile), indicating it is a material regional source for certain TB/interferon gamma assays.
Molecular, infectious-disease, and point-prevalence testing: Medicaid revenue shows substantial contributions from infectious disease and molecular codes — 80050 $641.2K (11.9% Medicaid), 87591 $474.9K (8.8%), 87491 $460.2K (8.5%), and U0004 $310.3K (5.8%). Combined with COVID-specific testing (87635 $171.2K, 3.2% Medicaid) and STD diagnostics, this mix suggests a business line that couples routine outpatient panels with high-throughput molecular infectious-disease services.
Non-panel and ancillary services: the provider bills meaningful amounts for drug screening and organism identification across payers, with 80307 at $113.6K (2.3% Medicare) and $272.9K (5.1% Medicaid), 87077 and 87186 providing culture and susceptibility revenue, and 87086 urine colony counts represented on Medicare ($114.6K, 2.4%). These lines suggest ancillary testing streams (toxicology and microbiology) that diversify revenue beyond routine chemistry panels.
Tenure and scale-up implication: the NPI was enumerated on 2022-04-27 (~4 years ago), and the rapid accrual of large claim volumes and multimillion-dollar lifetime revenue across both Medicare ($6.8M) and Medicaid ($7.8M) implies fast operational scale since enumeration. For payer analysts, this pattern signals a relatively recent entry to claims reporting but with rapid growth to a sizable regional testing platform.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
405 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 70,850 | $10 | $708.5K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 67,900 | $10 | $543.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 39,100 | $10 | $508.3K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 30,450 | $20 | $487.2K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 58,190 | $10 | $349.1K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 9,910 | $30 | $287.3K |
| 83880 | The lab analyst measures the amount of natriuretic peptide, a hormone made by heart muscle cells, in the patient specimen. Blood levels of the hormone increase in patients with congestive heart… | 6,420 | $40 | $244K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 5,500 | $40 | $220.1K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 22,550 | $10 | $203K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 14,330 | $10 | $114.6K |
Showing 1–10 of 405
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 405 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
405 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 39 | 40 | 1,090 | $30 | $188.7K |
| G0483 | 22 | 30 | 140 | $240 | $134.2K |
| G0482 | 35 | 40 | 310 | $190 | $108.9K |
| U0004 | 3 | 10 | 210 | $70 | $94.2K |
| 86481 | 1 | 10 | 960 | $100 | $92.5K |
| 87481 | 19 | 40 | 360 | $30 | $70.3K |
| 83970 | 2 | 20 | 170 | $40 | $47.2K |
| 81450 | 1 | 10 | 60 | $740 | $43.6K |
| 87186 | 3 | 10 | 2,880 | $10 | $43.5K |
| 83521 | 1 | 10 | 2,310 | $20 | $39.7K |
Showing 1–10 of 405
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
233 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 21,370 | $30 | $641.2K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 15,320 | $30 | $474.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 15,340 | $30 | $460.2K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 26,240 | $10 | $314.8K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 4,370 | $70 | $310.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 5,050 | $50 | $272.9K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 37,460 | $10 | $262.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 26,710 | $10 | $240.4K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 7,510 | $30 | $225.3K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 7,150 | $30 | $221.5K |
Showing 1–10 of 233
How this provider's Medicaid billing volume and revenue compare to other Oklahoma providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oklahoma median
233 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 83498 | The lab analyst measures the 17 hydroxyprogesterone in a sample such as blood, serum, urine, or even amniotic fluid. This hormone is a building block for the adrenal cortex hormone cortisol. | 5 | 10 | 300 | $30 | $782.5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 3 | 30 | 120 | $60 | $243.6K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 4 | 40 | 440 | $30 | $230.3K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 22 | 100 | 630 | $50 | $197.2K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 4 | 10 | 460 | $30 | $174.2K |
| 83013 | The lab analyst tests multiple breath samples for the presence of an isotope that indicates the presence of the H. pylori bacteria. This organism can cause irritation and ulcers of the stomach lining. | 3 | 10 | 120 | $60 | $166.9K |
| 87902 | The lab analyst performs the technical lab test to analyze the specific genotype by nucleic acid of a specimen containing hepatitis C virus. | 3 | 10 | 350 | $230 | $166K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 5 | 50 | 170 | $30 | $163.4K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 5 | 50 | 200 | $30 | $163.3K |
| 83020 | The lab analyst records and calculates the hemoglobin fractions in a whole blood sample demonstrated by this hemoglobin fractionation test by electrophoresis. | 5 | 10 | 230 | $10 | $130.2K |
Showing 1–10 of 233
Other providers in the same ZIP code as Labcorp Oklahoma, Inc., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.